RBC Capital and Mizuho Securities Stay Bullish on Surgery Partners (SGRY)

Company Overview - Surgery Partners, Inc. (NASDAQ:SGRY) operates a network of over 200 locations across 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices, and urgent care facilities [4] Analyst Ratings and Price Targets - RBC Capital has reiterated its Buy rating on Surgery Partners, Inc. with a price target of $31, indicating confidence in the company's long-term growth prospects [1] - Mizuho Securities has reduced its price target on Surgery Partners from $22 to $19 but maintains an Outperform rating, reflecting a cautious yet positive outlook [2] Industry Outlook - Mizuho Securities anticipates that 2026 will be a pivotal year for the managed care and health facilities sector, emerging from a three-year negative underwriting cycle [3] - Analysts expect improvements in margins across commercial insurance, Medicaid, and Medicare in the coming years, suggesting a recovery in the sector [3]